Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Zivo Bioscience Insiders Buying or Selling?
Zivo Bioscience (ZIVO) has had no reported insider transactions in the past 90 days. The most recent was MARK STROME, who bought 100,000 shares at $2.00 on April 17, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the ZIVO AI Score. For government officials trading this stock, see ZIVO congressional trading.
Who’s Trading Zivo Bioscience Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| MARK STROME | Bought $2.2M | 7 | Apr 17, 2026 |
| LAITH YALDOO | Bought $630,000 | 12 | Feb 27, 2026 |
| Christopher Maggiore | Bought $300,000 | 3 | Jan 14, 2026 |
| PAYNE JOHN BERNARD | Bought $210,000 | 3 | Jan 26, 2026 |
| Alison Cornell | Bought $100,000 | 1 | Jan 26, 2026 |
Recent Zivo Bioscience Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| MARK STROME | Apr 17, 2026 | Buy | 100,000 | $2 | $200,000 |
| LAITH YALDOO | Feb 27, 2026 | Buy | 1,543 | $9.72 | $15,000 |
| MARK STROME | Feb 12, 2026 | Buy | 20,000 | $9.77 | $200,000 |
| MARK STROME | Feb 12, 2026 | Buy | 2,000 | $0 | $0 |
| LAITH YALDOO | Feb 10, 2026 | Buy | 2,434 | $10.27 | $25,000 |
| Alison Cornell | Jan 26, 2026 | Buy | 11,709 | $8.54 | $100,000 |
| PAYNE JOHN BERNARD | Jan 26, 2026 | Buy | 11,709 | $8.54 | $100,000 |
| Christopher Maggiore | Jan 14, 2026 | Buy | 1,766 | $8.49 | $15,000 |
| LAITH YALDOO | Jan 14, 2026 | Buy | 1,766 | $8.49 | $15,000 |
| LAITH YALDOO | Nov 28, 2025 | Buy | 2,777 | $9 | $25,000 |
| MARK STROME | Oct 13, 2025 | Buy | 20,259 | $12.34 | $250,000 |
| MARK STROME | Oct 13, 2025 | Buy | 2,025 | $0 | $0 |
| LAITH YALDOO | Oct 10, 2025 | Buy | 1,659 | $12.05 | $20,000 |
| Christopher Maggiore | Oct 8, 2025 | Buy | 23,682 | $12.01 | $280,000 |
| LAITH YALDOO | Sep 30, 2025 | Buy | 15,322 | $15.99 | $240,000 |
| LAITH YALDOO | Jun 13, 2025 | Buy | 3,488 | $14.33 | $50,000 |
| LAITH YALDOO | Jun 13, 2025 | Buy | 348 | $14.33 | $5,000 |
| Christopher Maggiore | Apr 8, 2025 | Sell | 20 | $16.25 | $330 |
| LAITH YALDOO | Jan 22, 2025 | Buy | 7,200 | $17.53 | $130,000 |
| LAITH YALDOO | Jan 22, 2025 | Buy | 2,880 | $17.53 | $50,000 |
| MARK STROME | Dec 26, 2024 | Buy | 75,000 | $20.19 | $1.5M |
| MARK STROME | Dec 26, 2024 | Buy | 7,500 | $0 | $0 |
| PAYNE JOHN BERNARD | Oct 16, 2024 | Buy | 6,343 | $15.76 | $100,000 |
| LAITH YALDOO | Oct 16, 2024 | Buy | 3,133 | $15.96 | $50,000 |
| PAYNE JOHN BERNARD | Oct 16, 2024 | Buy | 634 | $15.77 | $10,000 |
| LAITH YALDOO | Oct 16, 2024 | Buy | 313 | $15.96 | $5,000 |
Frequently Asked Questions: Zivo Bioscience Insider Trading
Zivo Bioscience insiders have not reported any transactions in the past 90 days.
The most recent sale was by Christopher Maggiore who sold 20 shares on April 8, 2025. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
STROME MARK E has bought the most ZIVO stock in the last 2 years, with a total value of $2.2M.
Maggiore Christopher D. has sold the most ZIVO stock in the last 2 years, with a total value of $330.
According to our estimates, the total value of insider transactions for Zivo Bioscience in the last 2 years is positive, amounting to $3.4M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
